Related Experiment Video
Updated: May 20, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
[Imaging in Large-Vessel Vasculitis. What Works Best in Giant Cell Arteritis and Takayasu Arteritis?]
Insights
Giant cell arteritis and Takayasu arteritis are large-vessel vasculitides requiring prompt diagnosis. Advanced imaging techniques like ultrasound and MRI are crucial for detecting inflammation and guiding treatment to prevent complications.
Area of Science:
- Rheumatology
- Cardiology
- Radiology
Background:
- Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are primary systemic vasculitides affecting large vessels.
- GCA is the most common vasculitis, while TAK predominantly affects young women.
- Early diagnosis and treatment are crucial to prevent irreversible complications such as visual loss, stenosis, occlusion, and aneurysms.
Purpose of the Study:
- To review current and emerging imaging modalities for diagnosing and monitoring GCA and TAK.
- To highlight the strengths and limitations of various imaging techniques in assessing vascular inflammation and disease activity.
Main Methods:
- Vascular ultrasound for high-resolution assessment of cranial and extracranial vessels in GCA.
- Magnetic resonance imaging (MRI) as a gold standard for TAK, assessing mural inflammation and luminal pathology.
- 18F]FDG PET/CT for whole-body assessment in GCA and complementary role in TAK, despite limitations in specificity and persistent uptake.
- Emerging tracers ([18F]FAPI, [68Ga]Ga-DOTA-Siglec-9) and novel ocular imaging for GCA.
Main Results:
- Vascular ultrasound detects signs like the halo sign and increased intima-media thickness in GCA.
- MRI provides detailed, radiation-free assessment of inflammation and pathology in TAK.
- [18F]FDG PET/CT aids in identifying extracranial involvement in GCA but has limited specificity.
- Disease activity monitoring in both GCA and TAK remains challenging due to persistent vascular changes that may not reflect active inflammation.
Conclusions:
- Imaging plays a transformative role in the diagnosis and management of GCA and TAK.
- A multimodal imaging approach, combining ultrasound, MRI, and PET/CT, is often necessary for comprehensive evaluation.
- Ongoing research into novel imaging tracers and techniques promises to improve the accuracy and sensitivity of disease detection and monitoring.
Abstract:
Giant cell arteritis (GCA) is the most common primary systemic vasculitis and can present with a cranial, large-vessel, or mixed phenotype. Rapid and secure diagnosis is essential to prevent irreversible visual loss. Imaging has fundamentally transformed the diagnostic pathway. Vascular ultrasound is the first-line modality, enabling high-resolution assessment of both cranial and extracranial vessels, detecting pathological findings such as the halo sign, compression sign, and increased intima-media thickness. Magnetic resonance imaging (MRI) serves as an important complementary modality without radiation exposure. However, persistent mural signal abnormalities in large vessels limit activity assessment. Imaging with [18F]FDG positron emission tomography-computed tomography (PET/CT) enables whole-body assessment and identification of extracranial involvement but is constrained by limited specificity for inflammation and frequent persistent uptake in remission. Emerging tracers such as [18F]FAPI and [68Ga]Ga-DOTA-Siglec-9 may further improve imaging of inflammation in GCA. Similarly, novel ocular imaging modalities, including transorbital ultrasound and optical coherence tomography angiography, offer promising tools for detecting macro- and microvascular ophthalmologic involvement.
Abstract:
Takayasu arteritis (TAK), the second major large-vessel vasculitis, is predominantly affecting young women, involving only the aorta and its major branches. Early diagnosis is crucial, as ongoing inflammation leads to stenosis, occlusion, aneurysm formation, and ischemic complications. Imaging with MRI is the diagnostic gold standard, enabling detailed assessment of mural inflammation and luminal pathology without radiation exposure. Ultrasound supports rapid evaluation of accessible arteries, though it is limited for the thoracic aorta. Radiation-based imaging with [18F]FDG PET/CT and CT-angiography may complement MRI, but their use is constrained by radiation exposure which is particularly relevant in this young patient population. Disease activity monitoring remains challenging, as persistent mural thickening, IMT elevation, and [18F]FDG uptake may reflect vascular remodeling rather than active vasculitis.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

